Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ototoxicity × tempol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostate Cancer Recurrent 1 Ototoxicity 1 Mucositis 1 Glioblastoma 1 Dermatitis 1 Anus Neoplasms 1

Interventions

sodium thiosulfate 3 Cisplatin 3 tempol 1 ebselen 1 Vorinostat 1 Thioctic Acid 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Pantoprazole 1 Methotrexate 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Hyaluronic Acid 1 Hearing Tests 1 Dexamethasone 1 Chemotherapy, Adjuvant 1 Audiometry 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03480971 2024-11-20

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Matrix Biomed, Inc.

Phase 2 Recruiting

Ototoxicity, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡